The Positive
+ Strong leasing quarter with respectable reversions of 19.2% (1Q21: 9.5%; 2Q21: 13.3%). c.4.3% of portfolio NLA signed in 3Q21, 3.6x higher QoQ, of which, most were renewals. New leases formed 17.5% of NLA signed. Half of 3Q21 NLA signed was with a legal tenant, Arnall Golden Gregory, located in 171 17th Street in Atlanta. The tenant signed an early renewal on their leases expiring in 2024, which will extend its lease until 2035. Reversion for this lease was c.20%, while reversions for the remaining leases ranged from positive single digits to low double digits. A manageable 10.2% of leases by CRI are expiring in FY22. Passing rents for 10 out of 14 of Prime’s assets are currently below market rents, implying the potential for positive reversion averaging 7.5% for the portfolio. The is because growth in market rents has outpaced the scheduled escalations embedded in Prime’s leases.
The Negatives
– Two pre-terminations announced; pre-termination fees likely to cover rents till 4Q22. A tenant at One Washingtonian Center pre-terminated its lease, resulting in a 15ppt decline in building occupancy, from 95.6% to 80.6%. Pre-termination fees will cover rents till Nov22, providing upside for Prime, should the manager be able to lease out the space before pre-termination fees are depleted. WeWork, one of Prime’s top 10 tenant contributing 2.5% of CRI, announced the pre-termination of its lease at Tower I at Emeryville. WeWork’s security deposits, in the form of cash and other collaterals, will cover rents until 4Q22. More details to follow as Prime and WeWork are currently discussing the pre-termination fee and date of vacancy. Separately, a tenant occupying 2.6% of NLA at Reston Square will not be renewing its lease when it comes due in Jul22. The tenant was acquired by another corporate and will be relocating to the acquirer’s building. In place rents of US$443.46 are currently 14.7% above market rents of US$37.00, implying negative reversions for this space.
– Portfolio occupancy slipped 0.3ppts QoQ from 91.7% to 91.4%. This was largely attributed to the pre-termination at One Washingtonian Center.
Outlook
Adapting to earlier lease commencement dates. US leasing volume has picked up, with improvements lease tenures and reduction in tenant incentives. However, some tenants with larger footprints may require longer timeframes for decision making. The delay in decision making results in a more immediate intended occupancy date, as leases are signed closer to expiry. To adapt to tenants’ changing leasing behaviour, Prime is evaluating strategies to shorten the timeframe for tenants to move in. We think this could involve Prime pre-empting tenant’s space configurations and speculatively reconfiguring vacant spaces ahead of lease conclusion – a strategy that has garnered much success for one of its peers.
More significant return-to-office likely to happen in 1Q22. Physical occupancy for 3Q21 was c.30%, an improvement from c.20% in 2Q21. While many surveyed corporates expressed interest in returning to the office in 3Q21, new waves of the virus delayed return-to-office plans. We expect significant return-to-office will likely happen in 1Q22, delaying a more meaningful recovery in carpark income. For reference, carpark and ancillary income contribute c.7-9% of pre-pandemic revenue but is currently c.30-35% below stabilised levels.
Maintain ACCUMULATE and DDM TP of US$0.94.
No change in our estimates. Current share price implies FY21e/FY22e DPU yield of 7.6%/8.8%. Prime is our top pick in the sector for greater tenant exposure to STEM/TAMI sectors. Catalysts include improved leasing and a greater return to office.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
